Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
about
Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failureEffect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failureArtificial and bioartificial liver supportNo sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial.Bio-inspired detoxification using 3D-printed hydrogel nanocomposites.Evaluation of a novel hybrid bioartificial liver based on a multi-layer flat-plate bioreactor.Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.Artificial Organs 2006: a year in review.A case of living donor liver transplant recipient treated with novel blood purification "plasma diafiltration"Acute-on-chronic liver failure: a review.Artificial extracorporeal liver support therapy in patients with severe liver failure.Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.Available extracorporeal treatments for poisoning: overview and limitations.Cell and tissue engineering for liver disease.Comparison of two different modes of molecular adsorbent recycling systems for liver dialysis.Liver dialysis in acute-on-chronic liver failure: current and future perspectives.Development of high-efficiency molecular adsorbent recirculating system: preliminary report.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.Extracorporeal liver support devices for listed patients.Extracorporeal support for patients with acute and acute on chronic liver failure.[Acute-on-chronic liver failure: a diagnostic and therapeutic challenge for intensive care].Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis.Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems.Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption.
P2860
Q24676985-2BCE3CB9-61BE-4368-A049-F484DFD84E4CQ27499349-3C839CAE-1565-43AE-99CA-79AC29BC8D0CQ28237883-945DFFEE-A4A2-4050-A710-4A15D93D0071Q33417539-967FC4B8-E91B-453A-8C12-14568974B778Q33626659-043E172C-3141-43F4-BF14-BEDDC370A2B8Q36121265-930E05DE-D4A3-4B63-9A7C-89CEDF17E5D3Q36392462-E384F33E-9D13-4F1F-9035-4C2F26FF53D9Q36753747-048B3287-D08B-4351-9A3F-2FC87F5C56CDQ37311145-2EA4DF4A-0BCB-4624-9069-17F948349D1FQ37729728-288923A8-7A35-47B2-B6CD-B50866722FF6Q37930642-842F86DA-EE81-4359-B87F-AE4531ADCF08Q37955184-6D5888F1-A700-4F7D-A260-84D7849EF4BFQ38201806-759157DC-5E49-4CB1-94CC-C27059CAB18CQ38230357-FDEB1D0A-5A62-4766-8007-EA513F68DE55Q38437179-9D444F3E-5404-43CC-846A-C92E710B1F9FQ38442903-B85A77CA-2A98-4D03-BD9D-7E549EA17997Q38451211-8046E7E8-4797-478D-93A8-7AA9493EE600Q38456223-8B418307-C61D-4561-9EE9-BE2DA3827835Q38476335-709C9B33-3DF0-4250-A78C-B7FA4CE04B34Q38702799-68C15C82-420D-46BF-93B0-B70F111FE20BQ38740963-2BD24D7F-BB86-464D-972D-2B06A83D93CDQ40328569-19B4E9F4-B54D-453F-BE74-6E1C74B7747EQ44832218-58D558F4-A110-46C3-B5AE-2FD7E744FD04Q46784081-1D06CC8E-41F9-4824-A26A-097F014ED930Q46803998-CEBFAF3C-BF52-4859-8F99-16A70503C3AB
P2860
Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Prometheus versus molecular ad ...... liver detoxification devices.
@ast
Prometheus versus molecular ad ...... liver detoxification devices.
@en
Prometheus versus molecular ad ...... liver detoxification devices.
@nl
type
label
Prometheus versus molecular ad ...... liver detoxification devices.
@ast
Prometheus versus molecular ad ...... liver detoxification devices.
@en
Prometheus versus molecular ad ...... liver detoxification devices.
@nl
prefLabel
Prometheus versus molecular ad ...... liver detoxification devices.
@ast
Prometheus versus molecular ad ...... liver detoxification devices.
@en
Prometheus versus molecular ad ...... liver detoxification devices.
@nl
P2093
P2860
P50
P1433
P1476
Prometheus versus molecular ad ...... liver detoxification devices.
@en
P2093
Alexander Wilmer
Frederik Nevens
Kathleen Claes
Pieter Evenepoel
Yves Vanrenterghem
P2860
P304
P356
10.1111/J.1525-1594.2006.00215.X
P577
2006-04-01T00:00:00Z